Our findings confirm that SIRT1 plays an important role in the pathological changes in the hypothalamus in ALS even before the onset of motor changes, revealing SIRT1 as a potential target for therapeutic interventions to improve metabolic imbalance and sleep/wake disorder and even slow disease progression. The gene discussed is SIRT1; the disease is amyotrophic lateral sclerosis.